Overview

Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis

Status:
Completed
Trial end date:
2014-04-16
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to demonstrate the improvement in the skin condition rate of patients receiving alitretinoin compared to patients receiving placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Stiefel, a GSK Company
Collaborator:
Basilea Pharmaceutica
Treatments:
Alitretinoin
Tretinoin